title: [Aminoglycosides should still be used in empirical sepsis treatment].
authors.affiliation: Klinisk institutt 2, Medisinskodontologisk fakultet, Universitetet i Bergen, Norway. paul.lindemann@gades.uib.no
authors.forename: Paul Christoffer
authors.initials: PC
authors.lastname: Lindemann
authors.forename: Bjørg C
authors.initials: BC
authors.lastname: Haldorsen
authors.forename: Ingrid
authors.initials: I
authors.lastname: Smith
authors.forename: Haakon
authors.initials: H
authors.lastname: Sjursen
authors.forename: Haima
authors.initials: H
authors.lastname: Mylvaganam
mesh_terms: D000617:Aminoglycosides / Q000009:adverse effects / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D006801:Humans; D018805:Sepsis / Q000188:drug therapy*
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents